These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 20846089)
41. Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity. Chetan B; Bunha M; Jagrat M; Sinha BN; Saiko P; Graser G; Szekeres T; Raman G; Rajendran P; Moorthy D; Basu A; Jayaprakash V Bioorg Med Chem Lett; 2010 Jul; 20(13):3906-10. PubMed ID: 20605448 [TBL] [Abstract][Full Text] [Related]
42. Synthesis, evaluation of anticancer activity and COMPARE analysis of N-bis(trifluoromethyl)alkyl-N'-substituted ureas with pharmacophoric moieties. Luzina EL; Popov AV Eur J Med Chem; 2012 Jul; 53():364-73. PubMed ID: 22538016 [TBL] [Abstract][Full Text] [Related]
43. Design, synthesis and 3D-QSAR of beta-carboline derivatives as potent antitumor agents. Cao R; Guan X; Shi B; Chen Z; Ren Z; Peng W; Song H Eur J Med Chem; 2010 Jun; 45(6):2503-15. PubMed ID: 20304536 [TBL] [Abstract][Full Text] [Related]
44. Synthesis and cytostatic activity of purine nucleosides derivatives of allofuranose. Besada P; Costas T; Teijeira M; Terán C Eur J Med Chem; 2010 Dec; 45(12):6114-9. PubMed ID: 20934790 [TBL] [Abstract][Full Text] [Related]
45. Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: synthesis, cytostatic and antioxidative activity. Pavić K; Perković I; Cindrić M; Pranjić M; Martin-Kleiner I; Kralj M; Schols D; Hadjipavlou-Litina D; Katsori AM; Zorc B Eur J Med Chem; 2014 Oct; 86():502-14. PubMed ID: 25203780 [TBL] [Abstract][Full Text] [Related]
46. 3D-QSAR using pharmacophore-based alignment and virtual screening for discovery of novel MCF-7 cell line inhibitors. Brogi S; Papazafiri P; Roussis V; Tafi A Eur J Med Chem; 2013 Sep; 67():344-51. PubMed ID: 23880359 [TBL] [Abstract][Full Text] [Related]
47. Novel N-(3-carboxyl-9-benzyl-beta-carboline-1-yl)ethylamino acids: synthesis, anti-tumor evaluation, intercalating determination, 3D QSAR analysis and docking investigation. Wu J; Zhao M; Qian K; Lee KH; Morris-Natschke S; Peng S Eur J Med Chem; 2009 Oct; 44(10):4153-61. PubMed ID: 19535177 [TBL] [Abstract][Full Text] [Related]
48. Novel synthetic baicalein derivatives caused apoptosis and activated AMP-activated protein kinase in human tumor cells. Ding D; Zhang B; Meng T; Ma Y; Wang X; Peng H; Shen J Org Biomol Chem; 2011 Nov; 9(21):7287-91. PubMed ID: 21901221 [TBL] [Abstract][Full Text] [Related]
49. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship. Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907 [TBL] [Abstract][Full Text] [Related]
50. Gamma-lactones alpha,beta- and beta,gamma-fused to carbocycles as novel antiproliferative drugs. León LG; Machín RP; Rodríguez CM; Ravelo JL; Martín VS; Padrón JM Bioorg Med Chem Lett; 2008 Oct; 18(19):5171-3. PubMed ID: 18789684 [TBL] [Abstract][Full Text] [Related]
51. Synthesis and inhibition of cancer cell proliferation of (1,3')-bis-tetrahydroisoquinolines and piperazine systems. Aubry S; Pellet-Rostaing S; Fournier Dit Chabert J; Ducki S; Lemaire M Bioorg Med Chem Lett; 2007 May; 17(9):2598-602. PubMed ID: 17317166 [TBL] [Abstract][Full Text] [Related]
52. Synthesis and antiproliferative activity of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives: Part II. Shanab K; Schirmer E; Wulz E; Weissenbacher B; Lassnig S; Slanz R; Fösleitner G; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E Bioorg Med Chem Lett; 2011 May; 21(10):3117-21. PubMed ID: 21458262 [TBL] [Abstract][Full Text] [Related]
53. Design and synthesis of novel tetrahydro-2H-Pyrano[3,2-c]pyridazin-3(6H)-one derivatives as potential anticancer agents. Al-Tel TH Eur J Med Chem; 2010 Dec; 45(12):5724-31. PubMed ID: 20884086 [TBL] [Abstract][Full Text] [Related]
54. Synthesis and biological properties of new 5-nitroindazole derivatives. Arán VJ; Ochoa C; Boiani L; Buccino P; Cerecetto H; Gerpe A; González M; Montero D; Nogal JJ; Gómez-Barrio A; Azqueta A; López de Ceráin A; Piro OE; Castellano EE Bioorg Med Chem; 2005 May; 13(9):3197-207. PubMed ID: 15809155 [TBL] [Abstract][Full Text] [Related]
55. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line. Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and antitumor activity of ureas containing pyrimidinyl group. Jin C; Liang YJ; He H; Fu L Eur J Med Chem; 2011 Jan; 46(1):429-32. PubMed ID: 21144621 [TBL] [Abstract][Full Text] [Related]
57. Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives. Moorthy NS; Karthikeyan C; Trivedi P J Enzyme Inhib Med Chem; 2010 Jun; 25(3):394-405. PubMed ID: 20233012 [TBL] [Abstract][Full Text] [Related]
58. Synthesis and anticancer activity of N-bis(trifluoromethyl)alkyl-N'-thiazolyl and N-bis(trifluoromethyl)alkyl-N'-benzothiazolyl ureas. Luzina EL; Popov AV Eur J Med Chem; 2009 Dec; 44(12):4944-53. PubMed ID: 19740574 [TBL] [Abstract][Full Text] [Related]
59. Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer. Li Y; Zhang HB; Huang WL; Li YM Bioorg Med Chem Lett; 2008 Jun; 18(12):3652-5. PubMed ID: 18502125 [TBL] [Abstract][Full Text] [Related]
60. Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives. Shanab K; Schirmer E; Knafl H; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E Bioorg Med Chem Lett; 2010 Jul; 20(13):3950-2. PubMed ID: 20537894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]